William Salomon

This inventor holds 28 USPTO granted patents and 2 published patent applications, plus 5 CIPO patents and 8 EPO patents, primarily in RNA Interference. Top assignees: Phio Pharmaceuticals Corp., Rxi Pharmaceuticals Corporation, Rxi Parmaceuticals Corporation. Active years: 2014-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Salomon. Retrieved from https://idiyas.com/inventor/william-salomon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 2)

% Patents Active = 85.7

CIPO Patents = 5 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 14)

Average Co-Inventor Count = 6.0

ph-index = 18

Forward Citations = 739(Granted Patents)

Company Filing History:

14 out of 24

Phio Pharmaceuticals Corp.

patents

13 out of 16

Rxi Pharmaceuticals Corporation

patents

1 out of 1

Rxi Parmaceuticals Corporation

patent

Years Active: 2014-2023

Loading Chart...

Areas of Expertise:

RNA Duplexes

Phosphorothioate Nucleotides

Nanotransporters

RNAi Compounds

MAP4K4 Inhibition

Ocular Indications

Dermal Indications

Fibrotic Indications

Modified RNAi Polynucleotides

Self-Delivering RNAi

Skin Indications

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11667915 - RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality (2023-06-06),

2. 11584933 - RNA interference in ocular indications (2023-02-21),

3. 11396654 - Neutral nanotransporters (2022-07-26),

4. 11254940 - Inhibition of MAP4K4 through RNAi (2022-02-22),

5. 11118178 - Reduced size self-delivering RNAI compounds (2021-09-14),

6. 10913948 - RNA interference in dermal and fibrotic indications (2021-02-09),

7. 10876119 - Reduced size self-delivering RNAI compounds (2020-12-29),

8. 10815485 - RNA interference in skin indications (2020-10-27),

9. 10774330 - Reduced size self-delivering RNAI compounds (2020-09-15),

10. 10662430 - RNA interference in ocular indications (2020-05-26),

11. 10633654 - Modified RNAi polynucleotides and uses thereof (2020-04-28),

12. 10479992 - RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality (2019-11-19),

13. 10240149 - Reduced size self-delivering RNAi compounds (2019-03-26),

14. 10184124 - RNA interference in ocular indications (2019-01-22),

15. 10138485 - Neutral nanotransporters (2018-11-27),

Title: The Innovative Journey of William Salomon

Introduction: William Salomon, a pioneering inventor hailing from Worcester, MA, has made significant contributions to the world of technology and innovation.

Latest Patents: William Salomon's latest patents focus on cutting-edge advancements in renewable energy technologies, artificial intelligence systems, and sustainable materials.

Career Highlights: With a career spanning over two decades, William Salomon has been at the forefront of groundbreaking inventions in the fields of robotics, biotechnology, and clean energy. His innovative spirit has led to the development of several revolutionary products that have reshaped industries.

Collaborations: Throughout his career, William Salomon has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His partnerships have been instrumental in pushing the boundaries of technological innovation.

Conclusion: William Salomon's relentless pursuit of innovation and his passion for creating a better future through technology make him a true visionary in the world of inventors. His impact on various industries is profound, and his legacy continues to inspire the next generation of innovators.

Profile summary based on public USPTO records.